Ping An of China CSI HK Dividend ETF(03070.HK) fell 0.19% to HKD 42.760
Newtimespace News, as of 11:01 on May 6, Ping An of China CSI HK Dividend ETF(03070.HK) was quoted at HKD 42.760, down 0.19%. The ETF opened at HKD 43.000, with a high of HKD 43.000 and a low of HKD 42.560. The latest trading volume was 70,500 units, with a turnover of HKD 3.0131 million, and a turnover rate of 0.27%. The latest NAV per unit is HKD 42.798, with a premium rate of 0.10%. The asset size is approximately HKD 1.102 billion, and the total issuance is 25.75 million units.
Ping An of China CSI HK Dividend ETF(03070.HK) tracks the China Securities Hong Kong Dividend Index, which is compiled and published by China Securities Index Co., Ltd. The index aims to reflect the overall performance of stocks with high cash dividend yields, stable dividend distribution records, and a certain level of liquidity listed on The Stock Exchange of Hong Kong Limited. The index is calculated using a dividend yield weighting method, and its constituents broadly cover traditional high-dividend sectors such as finance, real estate, energy, and utilities. As the constituent companies are mostly mature enterprises with stable operations and strong cash flows, the index offers a relatively high dividend yield and exhibits lower volatility, making it an important allocation tool for investors seeking stable dividend income from the Hong Kong market.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- iShares China A50(02823.HK) up 0.69%, brokers eye post-holiday rebound
- Ruoyuchen(003010.SZ): Obtains CSRC Filing for H-Share Listing on HKEX
- DA SEN HLDGS (01580.HK): terminates placing of up to 219.12m new shares
- RIBOLIFE-B (06938.HK): files EU Phase I trial for obesity drug RBD3133
- BIREN TECH (06082.HK): places 130m new H shares at HKD 31.08 each